Butanal, 4-(octahydro-4,7-methano-5H-inden-5-ylidene)-
Common Name: |
Butanal, 4-(octahydro-4,7-methano-5H-inden-5-ylidene)- |
IUPAC Name: |
(4E)-4-(8-tricyclo[5.2.1.02,6]decanylidene)butanal |
Molecular Formula: |
C14H20O |
SMILES: |
C1CC2C(C1)C3CC2CC3=CCCC=O |
Inchi: |
1S/C14H20O/c15-7-2-1-4-10-8-11-9-14(10)13-6-3-5-12(11)13/h4,7,11-14H,1-3,5-6,8-9H2/b10-4+ |
Inchi Key: |
WFEISWUNAJPLRX-ONNFQVAWSA-N |
Cas No: |
30168-23-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
204.31 |
Mass (g/mol) |
204.151 |
Molar Refractivity |
62.80 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
3 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
110.00 @ 3.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.000441 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.79 |
LogP |
3.348 |
iLOGP |
2.68 |
XLOGP3 |
2.83 |
WLOGP |
3.35 |
MLOGP |
3.30 |
ESOL Log S |
-2.69 |
ESOL Solubility (mg/ml) |
0.416 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.85 |
Ali Solubility (mg/ml) |
0.29 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.52 |
Silicos-IT Solubility (mg/ml) |
0.62 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.54 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.913 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.168 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |